Breo Ellipta costs $350-$450 without insurance. Learn how to save with coupons, discount cards, manufacturer programs, and patient assistance in 2026.
If you've looked at the price tag on Breo Ellipta (fluticasone furoate/vilanterol) without insurance, you already know the problem: a single 30-dose inhaler can cost $350 to $450 at the pharmacy counter. That's a lot of money for a one-month supply of a medication you need every single day to manage your asthma or COPD.
The good news? There are real ways to bring that cost down significantly — sometimes to as little as $10 per month. In this guide, we'll walk you through every major savings option available for Breo Ellipta in 2026.
Let's start with the baseline numbers:
These prices reflect the typical retail cash price at major pharmacy chains. Prices vary by pharmacy and location, which is why shopping around can make a meaningful difference.
Because there is no FDA-approved generic for Breo Ellipta as of 2026, there's no lower-cost generic option available at the pharmacy counter. This makes savings programs and discount strategies especially important.
Prescription discount cards can reduce your out-of-pocket cost, especially if you're uninsured or your insurance doesn't cover Breo Ellipta.
This is the single best coupon option for most commercially insured patients:
If you have commercial insurance, this should be your first stop. Even if your insurance copay is $75-$150, the GSK savings card can bring it down to $10-$30.
If you're uninsured or the manufacturer coupon doesn't apply to you, these free discount card programs can help:
These cards are free to use and don't require insurance. Simply present the card or digital coupon at the pharmacy. Note that savings on brand-name drugs like Breo Ellipta may be more modest compared to generics — typically bringing the price down to $280-$380 rather than dramatically lower.
If you're uninsured or underinsured and can't afford Breo Ellipta at any price, you may qualify for free medication through a patient assistance program (PAP).
This is GSK's official patient assistance program for Breo Ellipta:
If your insurance covers Breo Ellipta, check whether your plan offers a mail-order option. Many plans provide a 90-day supply through mail-order at a lower per-dose cost than filling monthly at a retail pharmacy. This can save $20-$50+ per quarter depending on your plan.
Breo Ellipta prices vary between pharmacies — sometimes by $50 or more. Use Medfinder to compare prices and availability in your area. Don't assume your regular pharmacy has the best price.
Your doctor's office may have sample inhalers from GSK. While not a long-term solution, samples can help bridge a gap while you're applying for a patient assistance program or waiting for insurance authorization.
If cost is your primary concern and you're open to it, talk to your doctor about switching to a generic ICS/LABA alternative:
These alternatives require twice-daily dosing instead of once daily, but they can save you hundreds of dollars per month.
Depending on your state, additional assistance may be available:
No one should have to choose between breathing and paying their bills. Breo Ellipta is expensive, but between manufacturer coupons, patient assistance programs, discount cards, and generic alternatives, there are real paths to making it affordable.
Start with the GSK savings card if you have commercial insurance. If you're uninsured, apply to GSK For You. And if cost is still too high, talk to your doctor about more affordable alternatives that can provide the same type of asthma and COPD control.
Need to find Breo Ellipta in stock? Use Medfinder to check pharmacy availability near you.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.
%2C%20Color%3DOriginal.png)
